“Early personalization is often discussed as an enhancement rather than as a structural element of launch design,” said Emily ...
A worldwide leader in injectable drug administration will be the newest company to set up shop in Greenfield, and anticipates ...
TekniPlex Healthcare, which utilizes advanced materials science expertise to help deliver better patient outcomes, will ...
At the JPMorgan Healthcare Conference, Genmab emphasized a long-term growth strategy centered on disciplined R&D investment ...
Zacks Investment Research on MSN
Reasons to add West Pharmaceutical stock to your portfolio now
West Pharmaceutical Services, Inc. WST is well-positioned for growth, backed by a robust GLP-1-related demand and expansion ...
The plant will focus on serving health care companies by developing and commercializing medical devices, drug delivery ...
Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate R&D, betting on new modeling tools ...
Pune, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Pharmaceutical Market Size & Growth Analysis: “According to SNS Insider, the Global Pharmaceutical Market size was valued at USD 1598 Billion in 2023 and is ...
Now, it’s worth noting Stock Advisor’s total average return is 983 % — a market-crushing outperformance compared to 195% for ...
A company claiming to be “America’s Largest Ophthalmic Pharmacy” has issued a recall for multiple eye drop products for the ...
Zacks Investment Research on MSN
Teva Pharmaceutical Industries Ltd. (TEVA) is a top-ranked momentum stock: Should you buy?
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...
The initiative aims to balance pharmaceutical safety with the facilitation of trade and the smooth movement of shipments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results